Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2010
Headcount
2
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Reinvent Pharma is a patient-oriented company. The company is developing therapeutics based on a combination of approved drugs designed to improve the clinical outcome of immune and targeted therapies. The company's initial main field of interest is a selected niche of targeted solid tumors such as pancreatic, liver, bile duct, and brain tumors.
Q&A
- What is the current status of Reinvent Pharma?
- Reinvent Pharma is currently inactive and ceased to operate in February 2026.
- What was Reinvent Pharma's primary focus?
- Reinvent Pharma focused on developing immune-based anticancer technologies, specifically therapeutics designed to improve the clinical outcome of immune and targeted therapies for solid tumors like pancreatic, liver, bile duct, and brain tumors.
- When was Reinvent Pharma founded?
- Reinvent Pharma was founded in November 2010.
- How many employees did Reinvent Pharma have?
- Reinvent Pharma had 1-10 employees.
- Who was the Founder & CEO of Reinvent Pharma?
- Itschak Lamensdorf was the Founder & CEO of Reinvent Pharma.
- What was Reinvent Pharma's former name?
- Reinvent Pharma was formerly known as Pharmaseed Development.
- In which country was Reinvent Pharma headquartered?
- Reinvent Pharma was headquartered in Ness Ziona, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
immuno-theraphypharma-companiesdrug-discoverytargeted-therapytherapeuticsoncologypharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/18976543 |
Identifiers & details
| Former names | Pharmaseed Development |
|---|---|
| Founded | 2010-11 |
| Employees (exact) | 2 |
| Status reason | Non Active, Feb 2026 ceased to operate |